US 11155559
Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity
granted A61PA61P27/06A61P9/10
Quick answer
US patent 11155559 (Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity) held by CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED
- Grant date
- Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P27/06, A61P9/10, A61P9/12